A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

403

Participants

Timeline

Start Date

February 12, 2024

Primary Completion Date

October 31, 2027

Study Completion Date

April 30, 2028

Conditions
Advanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid TumorMetastatic Solid TumorNon Small Cell Lung CancerColorectal CancerKRAS G12CPancreatic Cancer
Interventions
DRUG

FMC-376

Oral Capsule

Trial Locations (21)

2109

NOT_YET_RECRUITING

Macquarie University, Macquarie Park

3128

NOT_YET_RECRUITING

Eastern Health - Box Hill Hospital, Box Hill

4215

RECRUITING

Tasman Health Care, Southport

5006

RECRUITING

GenesisCare North Adelaide, North Adelaide

5037

NOT_YET_RECRUITING

Icon Cancer Centre Kurralta Park, Kurralta Park

6009

RECRUITING

Linear Clinical Research Ltd, Nedlands

19104

RECRUITING

University of Pennsylvania, Philadelphia

22031

RECRUITING

Virginia Cancer Specialists, Fairfax

32746

RECRUITING

Florida Cancer Specialists and Research Institute, Lake Mary

46311

RECRUITING

Northwest Cancer Centers, Dyer

48201

RECRUITING

Karmanos Cancer Institute, Detroit

66205

RECRUITING

The University of Kansas Cancer Center, Fairway

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

77339

RECRUITING

Community Clinical Trials, Kingwood

78229

RECRUITING

South Texas Accelerated Research Therapeutics, LLC, San Antonio

RECRUITING

UT Health San Antonio, San Antonio

84119

RECRUITING

START Mountain Region, West Valley City

92037

RECRUITING

University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center, La Jolla

92868

RECRUITING

University of California Irvine (UCI) - Chao Family Comprehensive Cancer Center, Orange

94158

RECRUITING

University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

Sponsors
All Listed Sponsors
lead

Frontier Medicines Corporation

INDUSTRY